A comparative study of the effects of vitamin C, sirolimus, and paclitaxel on the growth of endothelial and smooth muscle cells for cardiovascular medical device applications

Antiproliferative drugs such as sirolimus (SIR) and paclitaxel (PAT) are currently released from stents and vascular grafts to inhibit the growth of smooth muscle cells (SMCs), thereby preventing neointimal hyperplasia. However, these drugs delay or impair the growth of endothelial cells (ECs) on im...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakade, Sandeep, Mani, Gopinath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699137/
https://www.ncbi.nlm.nih.gov/pubmed/23836963
http://dx.doi.org/10.2147/DDDT.S45162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699137/
https://www.ncbi.nlm.nih.gov/pubmed/23836963
http://dx.doi.org/10.2147/DDDT.S45162

Ejemplares similares